Two 59%+ winners, four above 25% in Aug – How this AI model keeps picking winners
Director Theodore Leonsis sold 44,000 shares of Tempus AI, Inc. NASDAQ:TEM on August 13, 2025. The shares were sold at a price of $69.90, for a total transaction value of $3.07 million. The stock, which has surged 21% in the past week and currently trades at $73.78, shows overbought conditions according to InvestingPro technical indicators. Following the transaction, Leonsis directly owns 15,511 shares of Class A Common Stock and indirectly owns 86,756 shares through the Theodore J. Leonsis Revocable Trust. The $12.4 billion company maintains a GOOD financial health score despite not being profitable in the last twelve months. Discover more insights and 8 additional key ProTips with InvestingPro’s comprehensive analysis.
In other recent news, Tempus AI Inc. reported its second-quarter 2025 earnings, exceeding revenue expectations with a total of $314.6 million, surpassing the forecast of $297.8 million. The company also reported a narrower-than-expected loss per share at -$0.22, compared to the anticipated -$0.25. These results indicate a positive financial performance for the quarter. TD Cowen raised its price target for Tempus AI to $72 from $62, maintaining a Buy rating due to stronger genomic volumes and a positive outlook for the company’s Ambry business. Meanwhile, Stifel reiterated its Hold rating on Tempus AI, keeping its price target steady at $65. These developments reflect varied analyst perspectives on the company’s future performance. Investors are closely monitoring these updates as they assess Tempus AI’s growth trajectory.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.